To investigate whether this rather important difference in tumor uptake was solely due to the difference in immunoreactivity and not because of reduced Fc-FcγR interactions as a result of glycan modifications, a follow-up experiment was conducted. This evidence concerns the gene FCGR2A and neoplasm.